Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene is annotated as a **novel pseudogene**, specifically an **ortholog of LOC103093635**, and is listed in Ensembl under the identifier ENSG00000284951. Pseudogenes are segments of DNA that resemble protein-coding genes but typically contain disruptive mutations such as frameshifts or premature stop codons that render them non-functional at the protein level[1][2]. While a subset of pseudogenes can retain regulatory functions at the RNA level or even regain some protein-coding capacity, the majority do not serve classic gene functions, and most are not drug or biomarker targets[2]. There is no evidence that this specific gene product is a receptor, enzyme, transporter, or otherwise therapeutically actionable molecule; it is included in genome annotation as a reference for sequence homology and evolutionary analysis. Additional notes: - "Novel pseudogene" means its parent protein-coding gene is identifiable, but this locus is not actively coding or functional[1][2]. - The presence of "ortholog of LOC103093635" suggests cross-species homology but does not change the nonfunctional annotation. - No approved drugs, known mechanisms of action, or biomarker relevance are associated with this pseudogene. - The entry is unsuitable as a therapeutic target and likely would be considered incorrect if cited as such. No further structural or functional information relevant to drug development or receptor biology is associated with ENSG00000284951 in available references[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel pseudogene, ortholog of LOC103093635 (ENSG00000284951).